Hogy Medical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
2,934.00
4,075.00
6,189.00
6,286.00
6,989.00
7,725.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
2,777.00
-1,694.00
726.00
51.00
-1,717.00
1,845.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
11,759.00
7,180.00
9,266.00
8,512.00
6,892.00
10,339.00
Cash Flow from Investing Activities
-4,121.00
-3,325.00
-2,041.00
-3,823.00
-6,988.00
-9,238.00
Cash Flow from Financing Activities
-5,455.00
-3,892.00
-3,142.00
-11,049.00
-2,500.00
-1,989.00
Net Cash Inflow / Outflow
2,711.00
273.00
4,531.00
-6,091.00
-2,746.00
-825.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
528.00
310.00
448.00
269.00
-150.00
63.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Hogy Medical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
2934
12024
-9,090.00
-75.60%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
2777
-2284
5,061.00
221.58%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
11759
9113
2,646.00
29.04%
Cash Flow from Investing Activities
-4121
-1801
-2,320.00
-128.82%
Cash Flow from Financing Activities
-5455
-9040
3,585.00
39.66%
Net Cash Inflow / Outflow
2711
-1654
4,365.00
263.91%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
528
74
454.00
613.51%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 63.77% vs -22.51% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
11,759.00
7,180.00
63.77%






